Stefan Sleijfer
Researcher Next ID · RN-033934
Researcher · Biochemistry, Genetics and Molecular Biology
Rotterdam, Netherlands
- Works count
- 663
- Citation count
- 28,931
- H-index
- 81
- i10-index
- 315
Research interests
Publications
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.08.1995
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.07.006
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2021 · https://doi.org/10.1016/j.annonc.2021.09.005
Pan-cancer whole-genome analyses of metastatic solid tumours
Nature · 2019 · https://doi.org/10.1038/s41586-019-1689-y
The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
Nature Genetics · 2019 · https://doi.org/10.1038/s41588-019-0507-7
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy018
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy310
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy095
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy096
Corrections to “Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”
Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy321
The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature
The Oncologist · 2016 · https://doi.org/10.1634/theoncologist.2016-0066
mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Clinical Cancer Research · 2011 · https://doi.org/10.1158/1078-0432.ccr-11-0255
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
Journal of Clinical Oncology · 2009 · 10.1200/jco.2008.21.3223
Current projects
No projects listed.